We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.11%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$10.9B
AUM Growth
+$354M
(+3.3%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
21.68%
Holding
2,365
New
95
Increased
251
Reduced
1,484
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$12.1M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$11.5M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$7.47M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$6.8M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$5.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$65.3M |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$17.5M |
| 3 |
Plains All American Pipeline
PAA
|
+$17.4M |
| 4 |
Apple
AAPL
|
+$15.4M |
| 5 |
Targa Resources
TRGP
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Financials | 13.41% |
| 3 | Healthcare | 12.54% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Industrials | 9.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Korro Bio
KRRO
$197M
| $97.7K | ﹤0.01% |
206
| – | – |
|
|
KBAL
2252
DELISTED
Kimball International
KBAL
| $92.6K | ﹤0.01% |
6,617
-8,992
| -58% | -$117K |
|
|
ISEE
2253
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $92.6K | ﹤0.01% |
14,981
-20,031
| -57% | -$122K |
|
2254
Ardelyx
ARDX
$1.03B
| $91.8K | ﹤0.01% |
13,865
-18,934
| -58% | -$130K |
|
|
CLVS
2255
DELISTED
Clovis Oncology, Inc.
CLVS
| $89.5K | ﹤0.01% |
12,751
-24,880
| -66% | -$167K |
|
2256
Precision BioSciences
DTIL
$205M
| $89.1K | ﹤0.01% |
287
-423
| -60% | -$148K |
|
|
GDEN
2257
DELISTED
Golden Entertainment
GDEN
| $87K | ﹤0.01% |
3,444
-4,095
| -54% | -$92K |
|
2258
Geron
GERN
$1.01B
| $83.4K | ﹤0.01% |
52,767
-75,063
| -59% | -$134K |
|
2259
CarParts.com
PRTS
$51.3M
| $83.3K | ﹤0.01% |
583
-921
| -61% | -$149K |
|
|
CMRX
2260
DELISTED
Chimerix, Inc.
CMRX
| $82.5K | ﹤0.01% |
+8,561
| New | +$78.6K |
|
|
SCU
2261
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $80.5K | ﹤0.01% |
+3,681
| New | +$72.8K |
|
2262
NewtekOne
NEWT
$370M
| $80.1K | ﹤0.01% |
+3,000
| New | +$68.5K |
|
2263
Lindblad Expeditions
LIND
$2.24B
| $78K | ﹤0.01% |
4,129
-8,026
| -66% | -$146K |
|
2264
AXT Inc
AXTI
$5.13B
| $76K | ﹤0.01% |
6,522
-10,415
| -61% | -$125K |
|
|
AGEN
2265
Agenus
AGEN
$311M
| $73.9K | ﹤0.01% |
1,385
-2,126
| -61% | -$154K |
|
|
NAGE
2266
Niagen Bioscience
NAGE
$242M
| $73.4K | ﹤0.01% |
+7,857
| New | +$62.3K |
|
2267
Universal Insurance Holdings
UVE
$1.18B
| $72.2K | ﹤0.01% |
5,037
-8,334
| -62% | -$125K |
|
2268
IDT Corp
IDT
$1.63B
| $72.1K | ﹤0.01% |
+3,180
| New | +$56.9K |
|
2269
Funko
FNKO
$331M
| $71.5K | ﹤0.01% |
3,632
-7,544
| -68% | -$105K |
|
|
BCEL
2270
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $71K | ﹤0.01% |
4,630
-7,690
| -62% | -$125K |
|
2271
Astronics
ATRO
$4.34B
| $66.2K | ﹤0.01% |
4,403
-8,484
| -66% | -$110K |
|
|
HT
2272
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $66.1K | ﹤0.01% |
6,269
-10,912
| -64% | -$105K |
|
2273
Dorian LPG
LPG
$1.91B
| $65.3K | ﹤0.01% |
4,972
-8,617
| -63% | -$114K |
|
|
WSR
2274
DELISTED
Whitestone REIT
WSR
| $64.5K | ﹤0.01% |
6,647
-12,958
| -66% | -$116K |
|
2275
Hackett Group
HCKT
$278M
| $62.3K | ﹤0.01% |
3,803
-7,348
| -66% | -$114K |
|
Similar funds
SPIA
BG
PCM
CS
HHII
LF
EIM
MetLife Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, MetLife Investment Management held 2,365 positions worth $10.9B, up 3.3% from $10.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
MetLife Investment Management withdrew a net $371M in Q1 2021, closing 53 positions and reducing 1,484 holdings. Its most notable exit was Plains All American Pipeline, an estimated $17.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, MetLife Investment Management opened a new position in NXP Semiconductors worth $13.3M.
- MetLife Investment Management's largest Q1 2021 buy was NXP Semiconductors: 66,011 shares worth $13.3M.
- MetLife Investment Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q1 2021, an estimated $11.5M increase.
- MetLife Investment Management's biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $65.3M.
- MetLife Investment Management fully exited Plains All American Pipeline in Q1 2021, selling an estimated $17.4M.
- MetLife Investment Management's ten largest holdings make up 22% of its $10.9B portfolio in Q1 2021.
- MetLife Investment Management opened 95 new positions and closed 53 in Q1 2021.
- MetLife Investment Management's portfolio value rose 3.3% quarter-over-quarter to $10.9B.
Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.